Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals Revenue

In the year 2023, Pieris Pharmaceuticals had annual revenue of $42.81M with 65.28% growth. Revenue in the quarter ending December 31, 2023 was $1.30M, a -77.78% decrease year-over-year.

• Revenue (ttm): $42.81M
• Revenue Growth: +65.28%
• P/S Ratio: 0.34
• Revenue / Employee: $930,652
• Employees: 46
• Market Cap: 14.49M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	42.81M	16.91M	65.28%
Dec 31, 2022	25.90M	-5.52M	-17.56%
Dec 31, 2021	31.42M	2.10M	7.14%
Dec 31, 2020	29.32M	-16.96M	-36.64%
Dec 31, 2019	46.28M	17.18M	59.03%
Dec 31, 2018	29.10M	3.83M	15.14%
Dec 31, 2017	25.28M	19.44M	333.46%
Dec 31, 2016	5.83M	2.90M	98.88%
Dec 31, 2015	2.93M	-2.43M	-45.35%
Dec 31, 2014	5.37M	-7.06M	-56.83%
Dec 31, 2013	12.43M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.